The maintenance of an inflammatory TME is further stabilized through the JAK/STAT and the IKK/NF- χβ pathways, whose effects are robustly sustained by a feedback from cancer cells through the production of inflammatory cytokines such as IL-1β, IL-6 and TNF-α [57–61]. Here, IL1B is linked to cancer.